Environmental Substances Associated with Osteoporosis-A Scoping Review

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Jan 20

PMID 33467108

Citations 15

Authors

Hanna Elonheimo

Rosa Lange

Hanna Tolonen

Marike Kolossa-Gehring

Affiliations

Soon will be listed here.

Abstract

Introduction: Osteoporosis is a disease having adverse effects on bone health and causing fragility fractures. Osteoporosis affects approximately 200 million people worldwide, and nearly 9 million fractures occur annually. Evidence exists that, in addition to traditional risk factors, certain environmental substances may increase the risk of osteoporosis.

Methods: The European Human Biomonitoring Initiative (HBM4EU) is a joint program coordinating and advancing human biomonitoring in Europe. HBM4EU investigates citizens' exposure to several environmental substances and their plausible health effects aiming to contribute to policymaking. In HBM4EU, 18 priority substances or substance groups were selected. For each, a scoping document was prepared summarizing existing knowledge and health effects. This scoping review is based on these chemical-specific scoping documents and complementary literature review.

Results: A possible link between osteoporosis and the body burden of heavy metals, such as cadmium (Cd) and lead (Pb), and industrial chemicals such as phthalates and per- and poly-fluoroalkyl substances (PFASs) was identified.

Conclusions: Evidence shows that environmental substances may be related to osteoporosis as an adverse health effect. Nevertheless, more epidemiological research on the relationship between health effects and exposure to these chemicals is needed. Study results are incoherent, and pervasive epidemiological studies regarding the chemical exposure are lacking.

Citing Articles

PMA-Zeolite: Chemistry and Diverse Medical Applications.

Bulog A, Pavelic K, Sutic I, Kraljevic Pavelic S J Funct Biomater. 2024; 15(10).

PMID: 39452594 PMC: 11509060. DOI: 10.3390/jfb15100296.

Effect of Zinc Supplementation on Altered Calcium Homeostasis, Parathyroid Gland, Bone, and Skeletal Muscle Histology Induced by Subchronic Oral Exposure to Glyphosate-Based Herbicide (GOBARA) in Wistar Rats.

Tizhe E, Igbokwe I, Njokwu C, Fatihu M, Tizhe U, Ibrahim N Clin Pathol. 2024; 17:2632010X241265854.

PMID: 39070950 PMC: 11282526. DOI: 10.1177/2632010X241265854.

The association between different impact exercises and osteoporosis: an analysis of data from the Taiwan biobank.

Wu M, Nfor O, Ho C, Lu W, Liaw Y BMC Public Health. 2024; 24(1):1881.

PMID: 39010045 PMC: 11247905. DOI: 10.1186/s12889-024-19403-y.

Unveiling the unexplored novel signatures for osteoporosis via a detailed bioinformatics and molecular experiments based approach.

Zhou H, Gul Y, Hameed Y, Alhomrani M, Alghamdi S, Almalki A Am J Transl Res. 2024; 16(4):1306-1321.

PMID: 38715824 PMC: 11070346. DOI: 10.62347/TAYD3318.

Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?.

Skoracka K, Hryhorowicz S, Tovoli F, Raiteri A, Rychter A, Slomski R Calcif Tissue Int. 2023; 114(2):98-109.

PMID: 38049681 PMC: 10803478. DOI: 10.1007/s00223-023-01155-3.

References

Alswat K . Gender Disparities in Osteoporosis. J Clin Med Res. 2017; 9(5):382-387. PMC: 5380170. DOI: 10.14740/jocmr2970w. View

Engstrom A, Michaelsson K, Vahter M, Julin B, Wolk A, Akesson A . Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone. 2012; 50(6):1372-8. DOI: 10.1016/j.bone.2012.03.018. View

Axmon A, Axelsson J, Jakobsson K, Lindh C, Jonsson B . Time trends between 1987 and 2007 for perfluoroalkyl acids in plasma from Swedish women. Chemosphere. 2014; 102:61-7. DOI: 10.1016/j.chemosphere.2013.12.021. View

Wittassek M, Koch H, Angerer J, Bruning T . Assessing exposure to phthalates - the human biomonitoring approach. Mol Nutr Food Res. 2010; 55(1):7-31. DOI: 10.1002/mnfr.201000121. View

Sucharew H, Macaluso M . Progress Notes: Methods for Research Evidence Synthesis: The Scoping Review Approach. J Hosp Med. 2019; 14(7):416-418. DOI: 10.12788/jhm.3248. View

Chen X, Wang K, Wang Z, Gan C, He P, Liang Y . Effects of lead and cadmium co-exposure on bone mineral density in a Chinese population. Bone. 2014; 63:76-80. DOI: 10.1016/j.bone.2014.02.017. View

Ganzleben C, Antignac J, Barouki R, Castano A, Fiddicke U, Klanova J . Human biomonitoring as a tool to support chemicals regulation in the European Union. Int J Hyg Environ Health. 2017; 220(2 Pt A):94-97. DOI: 10.1016/j.ijheh.2017.01.007. View

Akesson A, Barregard L, Bergdahl I, Nordberg G, Nordberg M, Skerfving S . Non-renal effects and the risk assessment of environmental cadmium exposure. Environ Health Perspect. 2014; 122(5):431-8. PMC: 4014752. DOI: 10.1289/ehp.1307110. View

Reginster J, Burlet N . Osteoporosis: a still increasing prevalence. Bone. 2006; 38(2 Suppl 1):S4-9. DOI: 10.1016/j.bone.2005.11.024. View

10.

Apel P, Rousselle C, Lange R, Sissoko F, Kolossa-Gehring M, Ougier E . Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment. Int J Hyg Environ Health. 2020; 230:113622. DOI: 10.1016/j.ijheh.2020.113622. View

11.

Campbell J, Auinger P . The association between blood lead levels and osteoporosis among adults--results from the third national health and nutrition examination survey (NHANES III). Environ Health Perspect. 2007; 115(7):1018-22. PMC: 1913605. DOI: 10.1289/ehp.9716. View

12.

Min K, Min J . Urinary phthalate metabolites and the risk of low bone mineral density and osteoporosis in older women. J Clin Endocrinol Metab. 2014; 99(10):E1997-2003. DOI: 10.1210/jc.2014-2279. View

13.

Nash D, Magder L, Sherwin R, Rubin R, Silbergeld E . Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2004; 160(9):901-11. DOI: 10.1093/aje/kwh296. View

14.

Khalil N, Chen A, Lee M, Czerwinski S, Ebert J, DeWitt J . Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010. Environ Health Perspect. 2015; 124(1):81-7. PMC: 4710590. DOI: 10.1289/ehp.1307909. View

15.

Apel P, Angerer J, Wilhelm M, Kolossa-Gehring M . New HBM values for emerging substances, inventory of reference and HBM values in force, and working principles of the German Human Biomonitoring Commission. Int J Hyg Environ Health. 2016; 220(2 Pt A):152-166. DOI: 10.1016/j.ijheh.2016.09.007. View

16.

Wilhelm M, Heinzow B, Angerer J, Schulz C . Reassessment of critical lead effects by the German Human Biomonitoring Commission results in suspension of the human biomonitoring values (HBM I and HBM II) for lead in blood of children and adults. Int J Hyg Environ Health. 2010; 213(4):265-9. DOI: 10.1016/j.ijheh.2010.04.002. View

17.

Esteban M, Castano A . Non-invasive matrices in human biomonitoring: a review. Environ Int. 2008; 35(2):438-49. DOI: 10.1016/j.envint.2008.09.003. View

18.

Prozialeck W, Edwards J . Early biomarkers of cadmium exposure and nephrotoxicity. Biometals. 2010; 23(5):793-809. DOI: 10.1007/s10534-010-9288-2. View

19.

Fromme H, Tittlemier S, Volkel W, Wilhelm M, Twardella D . Perfluorinated compounds--exposure assessment for the general population in Western countries. Int J Hyg Environ Health. 2008; 212(3):239-70. DOI: 10.1016/j.ijheh.2008.04.007. View

20.

Lv Y, Wang P, Huang R, Liang X, Wang P, Tan J . Cadmium Exposure and Osteoporosis: A Population-Based Study and Benchmark Dose Estimation in Southern China. J Bone Miner Res. 2017; 32(10):1990-2000. DOI: 10.1002/jbmr.3151. View